Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Auction winner gets to keep her moon rock bag after court battle with NASA

Add as a preferred source on Google

It seems that Nancy Carlson of Inverness, Illinois spent $995 to buy a small, rather innocuous looking “lunar sample return bag” at an auction held by the U.S. Marshals Service. No problem there, right? Go shopping, place the winning bid, pay the amount, have a nice day. Ah, but there’s more to the story than meets the eye.

Houston, we do indeed have a problem.

Recommended Videos

According to the website collectSPACE.com, the bag came to be at the auction after it was “forfeited along with other artifacts found in the home of Max Ary, a former curator convicted in 2006 of stealing and selling space artifacts that belonged to the Cosmosphere space museum in Hutchinson, Kansas.” Ary spent two years in prison and was fined $132,000.

The story on collectSPACE also notes that the bag’s history “was only discovered after Carlson sent the artifact to NASA to be tested for the presence of moon dust.” NASA checked it out and concluded that there was lunar evidence present. The space agency seized the item and gave the Department of Justice a call. In the now-resolved court case, the government maintained that due to a mix-up, the lunar sample bag was not properly identified as coming from the historic Apollo 11 flight.

Had it been marked correctly, the lunar sample bag wouldn’t have ended up on an auction block. However, in his ruling this week, Judge J. Thomas Marten said Carlson was “a good faith purchaser, in a sale conducted according to law.” Basically, she bought what was made available to her at a legally conducted auction.

KMBC News notes that Carlson knew the bag came from a moon flight — she just didn’t know it came from the one that first put men on the moon. She now has the title to the bag but must file a motion in the U.S. District Court for Texas to get it back from the NASA Johnson Space Center in Houston.

Brinke Guthrie
Former Contributor
Brinke’s favorite toys include his Samsung Galaxy Tab S, Toshiba Chromebook 2, Motorola Moto G4, and two Kindles. A…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more